Induction of liver cytochrome P450 1A2 expression by flutamide in rats

被引:5
|
作者
Wang, HX
Liu, X
Xu, CJ
Ma, XC
Long, JE
Li, D [1 ]
机构
[1] Fudan Univ, Sch Basic Med Sci, Inst Mol Virus, Shanghai 200031, Peoples R China
[2] Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai 200032, Peoples R China
[3] Chinese Acad Sci, Shanghai Inst Mat Med, Inst Biol Sci, State Key Lab Drug Res, Shanghai 200031, Peoples R China
关键词
flutamide; cytochrome P450 1A2; induction;
D O I
10.1111/j.1745-7254.2005.00211.x
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Aim: To investigate the modulation of liver cytochrome P450 1A2 (CYP1A2) expression by giving flutamide to adult rats. Methods: Rats were given 50, 100, and 200 mg/kg po of flutamide for 2 weeks. Liver CYP1A2 mRNA was measured using reverse transcription-polymerase chain reaction. CYP 1A2 protein was detected using immunoblotting. CYP1A2 activity was assayed using high performance liquid chromatography, with caffeine as the CYP1A2 substrate. Results: CYP1A2 mRNA levels after flutamide treatment at 100 mg/kg and 200 mg/kg were, respectively, 1.86 and 3.11-fold higher than those of the control. Correspondingly, CYP1A2 protein increased 1.78 and 2.89-fold and CYP1A2 activity increased approximately 1.65 and 2.83-fold, respectively, relative to controls. Flutamide treatment at 50 mg/kg had no significant effect on CYP1A2 mRNA, protein, or enzyme activity. Conclusion: Giving rats flutamide induced liver CYP1A2 expression in a dose-dependent manner.
引用
收藏
页码:1382 / 1386
页数:5
相关论文
共 50 条
  • [21] Conformational change of cytochrome P450 1A2 induced by phospholipids
    Yun, CH
    Song, M
    Kim, H
    FASEB JOURNAL, 1997, 11 (09): : A810 - A810
  • [22] Modeling of complexes between cytochrome P450 1A2 and substrates
    Pogrebnoy, A. A.
    Grishina, M. A.
    Potemkin, V. A.
    JOURNAL OF STRUCTURAL CHEMISTRY, 2009, 50 (05) : 814 - 820
  • [23] Cytochrome P450 1A2 Detoxicates Aristolochic Acid in the Mouse
    Rosenquist, Thomas A.
    Einolf, Heidi J.
    Dickman, Kathleen G.
    Wang, Lai
    Smith, Amanda
    Grollman, Arthur P.
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (05) : 761 - 768
  • [24] New Specific Marker of Cytochrome P450 1A2 Activity
    A. A. Filimonova
    L. E. Ziganshina
    A. U. Ziganshin
    A. A. Chichirov
    Bulletin of Experimental Biology and Medicine, 2011, 150 : 762 - 764
  • [25] Genetic polymorphism of cytochrome P450 1A2 in a Korean population
    Lee, JE
    Lee, SS
    Shin, JG
    DRUG METABOLISM REVIEWS, 2004, 36 : 109 - 109
  • [26] Tizanidine is mainly metabolized by cytochrome P450 1A2 in vitro
    Granfors, MT
    Backman, JT
    Laitila, J
    Neuvonen, PJ
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 57 (03) : 349 - 353
  • [27] Pharmacologic profiling of human and rat cytochrome P450 1A1 and 1A2 induction and competition
    Walter M. A. Westerink
    Joe C. R. Stevenson
    Willem G. E. J. Schoonen
    Archives of Toxicology, 2008, 82 : 909 - 921
  • [28] New Specific Marker of Cytochrome P450 1A2 Activity
    Filimonova, A. A.
    Ziganshina, L. E.
    Ziganshin, A. U.
    Chichirov, A. A.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2011, 150 (06) : 762 - 764
  • [29] Metabolism and Mechanism of Human Cytochrome P450 Enzyme 1A2
    Guo, Jingchao
    Zhu, Xiaohui
    Badawy, Sara
    Ihsan, Awais
    Liu, Zhenli
    Xie, Changqing
    Wang, Xu
    CURRENT DRUG METABOLISM, 2021, 22 (01) : 40 - 49
  • [30] Pharmacologic profiling of human and rat cytochrome P450 1A1 and 1A2 induction and competition
    Westerink, Walter M. A.
    Stevenson, Joe C. R.
    Schoonen, Willem G. E. J.
    ARCHIVES OF TOXICOLOGY, 2008, 82 (12) : 909 - 921